Sequential 123I-iododexetimide scans in temporal lobe epilepsy: Comparison with neuroimaging scans (MR imaging and 18F-FDG PET imaging)

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 2, 2005, Pages 180-185

  Mohamed, Armin ^a,b   Eberl, Stefan ^a   Fulham, Michael J ^a,b   Kassiou, Michael ^a,b   Zaman, Aysha ^b   Henderson, David ^a   Beveridge, Scott ^a   Constable, Chris ^a   Sing, Kai Lo ^c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Iododexetimide; Muscarinic acetylcholine receptors; Radionuclide imaging; SPECT; Temporal lobe epilepsy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IODINE 123; IODODEXETIMIDE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; DEXETIMIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; N METHYL 4 IODODEXETIMIDE; N-METHYL-4-IODODEXETIMIDE;

ADULT; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAPHY; EPILEPSY; FEMALE; HIPPOCAMPUS; HUMAN; LIGAND BINDING; MALE; MEDICAL ASSESSMENT; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; BRAIN MAPPING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; BRAIN MAPPING; DEXETIMIDE; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 13844250301     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1654-2     Document Type: Article

References (25)

1. McNamara JO. Selective alterations of regional beta-adrenergic receptor binding in the kindling model of epilepsy. Exp Neurol 1978;61(3):582-91.
2. Cavalheiro EA. The pilocarpine model of epilepsy. Ital J Neurol Sci 1995;16(1-2):33-7.
3. Cruickshank JW, Brudzynski SM, McLachlan RS. Involvement of M1 muscarinic receptors in the initiation of cholinergically induced epileptic seizures in the rat brain. Brain Res 1994;643(1-2):125-9.
4. Dasheiff RM, Savage DD, McNamara JO. Seizures downregulate muscarinic cholinergic receptors in hippocampal formation. Brain Res 1982;235(2):327-34.
5. Danober L, Depaulis A, Marescaux C, Vergnes M. Effects of cholinergic drugs on genetic absence seizures in rats. Eur J Pharmacol 1993;234(2-3):263-8.
6. Dickson CT, Alonso A. Muscarinic induction of synchronous population activity in the entorhinal cortex. J Neurosci 1997;17(17):6729-44.
7. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS, et al. Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 1997;94(24):13311-6.
8. Laird HE II, Hadjiconstantinou M, Neff NH. Abnormalities in the central cholinergic transmitter system of the genetically epilepsy-prone rat. Life Sci 1986;39(9):783-7.
9. Morrisett RA, Jope RS, Snead OC 3rd. Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp Neurol 1987;97(1):193-200.
10. Green RC, Blume HW, Kupferschmid SB, Mesulam MM. Alterations of hippocampal acetylcholinesterase in human temporal lobe epilepsy. Ann Neurol 1989;26(3):347-51.
11. Kish SJ, Olivier A, Dubeau F, Robitaille Y, Sherwin AL. Increased activity of choline acetyl transferase and acetylcholinesterase in actively epileptic human cerebral cortex. Epilepsy Res 1988;2:227-31.
12. 123I]4-iodolevetimide. J Cereb Blood Flow Metab 1992;12(4):562-70.
13. Boundy KL, Rowe CC, Black AB, Kitchener MI, Barnden LR, Sebben R, et al. Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography. Neurology 1996; 47(4):1015-20.
14. Hooper PK, Meikle SR, Eberl S, Fulham MJ. Validation of post injection; transmission measurements for attenuation correction in neurologic FDG PET studies. J Nucl Med 1996; 37:128-36.
15. Eberl S, Anayat AR, Fulton RR, Hooper PK, Fulham MJ. Evaluation of two population-based input functions for quantitative FDG PET studies. Eur J Nucl Med 1997;24:299-304.
16. 123I]-4- iododexetimide, a potent muscarinic cholinergic receptor antagonist. J Med Chem 1989;32:1057-62.
17. 123I]N-methyl-4-iodolevetimide: in vitro and in vivo characterisation of binding to muscarinic receptors in the rat heart. Nucl Med Biol 1996;23(2):147-53.
18. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 1994;13:601-9.
19. Meikle SR, Hutton BF, Bailey DL. A transmission-dependent method for scatter correction in SPECT. J Nucl Med 1994; 35:360-7.
20. Eberl S, Kanno I, Fulton R, Ryan A, Hutton BF, Fulham MJ. Automated interstudy image registration technique for SPECT and PET. J Nucl Med 1996;37:137-45.
21. Ardekani BA, Braun M, Hutton BF, Kanno I, Iida H. A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr 1995;19:615-23.
22. Bronen RA, Cheung G. Relationship of hippocampus and amygdala to coronal MRI landmarks. J Magn Reson Imaging 1991;9(3):449-57.
23. Boundy KL, Barnden LR, Rowe CC, Reid M, Kassiou M, Katsifis AG, Lambrecht RM. Human dosimetry and biodistribution of iodine-123-iododexetimide: a SPECT imaging agent for cholinergic muscarinic neuroreceptors. J Nucl Med 1995; 36(7):1332-8.
24. Newton MR, Berkovic SF, Austin MC, Rowe CC, McKay WJ, Bladin PF. Ictal postictal and interictal single-photon emission tomography in the lateralization of temporal lobe epilepsy. Eur J Nucl Med 1994;21(10):1067-71.
25. 123I-iododexetimide and single-photon emission computed tomography in epilepsy. Ann Neurol 1993;34(2):235-8.